NEW YORK, Feb. 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
Month: February 2024
NEW YORK, Feb. 24, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Mobileye Global Inc. (NASDAQ: MBLY) between January 26, 2023 and January 3, 2024, both dates inclusive (the “Class Period”), of the important March 18, 2024…
BARCELONE, Espagne, 24 février 2024 /PRNewswire/ — L’avènement de la 5G offre une bande passante élevée et une faible latence, ce qui améliore considérablement la puissance de calcul du réseau. Sur cette base, New Calling favorise la transition de l’appel vocal et vidéo vers des…
NEW YORK, Feb. 24, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against InMode Ltd. (“InMode” or the “Company”) (NASDAQ: INMD).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),…
NEW YORK, Feb. 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Feb. 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc (“Waldencast” or the “Company”) (NASDAQ: WALD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of SSR Mining Inc. (“SSR” or the “Company”) (NASDAQ: SSRM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Feb. 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Repare Therapeutics Inc. (“Repare” or the “Company”) (NASDAQ: RPTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Exscientia plc (“Exscientia” or the “Company”) (NASDAQ: EXAI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 24, 2024` /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Snap Inc. (“Snap” or the “Company”) (NYSE: SNAP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns…
